Emerging roles of E2Fs in cancer: an exit from cell cycle control

被引:805
作者
Chen, Hui-Zi [1 ,2 ,3 ]
Tsai, Shih-Yin [1 ,2 ]
Leone, Gustavo [1 ,2 ,3 ]
机构
[1] Ohio State Univ, Human Canc Genet Program, Dept Mol Virol Immunol & Med Genet, Columbus, OH 43210 USA
[2] Ohio State Univ, Dept Mol Genet, Columbus, OH 43210 USA
[3] Ohio State Univ, Ctr Comprehens Canc, Coll Med & Publ Hlth, Integrated Med Sci Program, Columbus, OH 43210 USA
基金
美国国家卫生研究院;
关键词
COMPARATIVE GENOMIC HYBRIDIZATION; TRANSCRIPTION FACTOR E2F-1; TRANSGENIC MOUSE MODEL; PROTEIN FAMILY-MEMBERS; LOSS-OF-HETEROZYGOSITY; HUMAN LUNG-CANCER; LENS FIBER CELLS; S-PHASE ENTRY; HEPATOCELLULAR-CARCINOMA; GENE-EXPRESSION;
D O I
10.1038/nrc2696
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Mutations of the retinoblastoma tumour suppressor gene (RB1) or components regulating the RB pathway have been identified in almost every human malignancy. The E2F transcription factors function in cell cycle control and are intimately regulated by RB. Studies of model organisms have revealed conserved functions for E2Fs during development, suggesting that the cancer-related proliferative roles of E2F family members represent a recent evolutionary adaptation. However, given that some human tumours have concurrent RB1 inactivation and E2F amplification and overexpression, we propose that there are alternative tumour-promoting activities for the E2F family, which are independent of cell cycle regulation.
引用
收藏
页码:785 / 797
页数:13
相关论文
共 215 条
[1]   Microarray-based CGH of sporadic and syndrome-related pheochromocytomas using a 0.1-0.2 Mb bacterial artificial chromosome array spanning chromosome arm 1p [J].
Aarts, M ;
Dannenberg, H ;
deLeeuw, RJ ;
van Nederveen, FH ;
Verhofstad, AA ;
Lenders, JW ;
Dinjens, WNM ;
Speel, EJM ;
Lam, WL ;
de Krijger, RR .
GENES CHROMOSOMES & CANCER, 2006, 45 (01) :83-93
[2]   Expression of transcription factor E2F1 and telomerase in glioblastomas: Mechanistic linkage and prognostic significance [J].
Alonso, MM ;
Fueyo, J ;
Shay, JW ;
Aldape, KD ;
Jiang, H ;
Lee, OH ;
Johnson, DG ;
Xu, J ;
Kondo, Y ;
Kanzawa, T ;
Kyo, S ;
Bekele, BN ;
Zhou, X ;
Nigro, J ;
McDonald, JM ;
Yung, WKA ;
Gomez-Manzano, C .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2005, 97 (21) :1589-1600
[3]   dE2F2-independent rescue of proliferation in cells lacking an activator dE2F1 [J].
Ambrus, Aaron M. ;
Nicolay, Brandon N. ;
Rasheva, Vanya I. ;
Suckling, Richard J. ;
Frolov, Maxim V. .
MOLECULAR AND CELLULAR BIOLOGY, 2007, 27 (24) :8561-8570
[4]   Strength in numbers: preventing rereplication via multiple mechanisms in eukaryotic cells [J].
Arias, Emily E. ;
Walter, Johannes C. .
GENES & DEVELOPMENT, 2007, 21 (05) :497-518
[5]   Repression of the Arf tumor suppressor by E2F3 is required for normal cell cycle kinetics [J].
Aslanian, A ;
Iaquinta, PJ ;
Verona, R ;
Lees, JA .
GENES & DEVELOPMENT, 2004, 18 (12) :1413-1422
[6]   The E2F family: specific functions and overlapping interests [J].
Attwooll, C ;
Denchi, EL ;
Helin, K .
EMBO JOURNAL, 2004, 23 (24) :4709-4716
[7]   The quest for the 1p36 tumor suppressor [J].
Bagchi, Anindya ;
Mills, Alea A. .
CANCER RESEARCH, 2008, 68 (08) :2551-2556
[8]  
Bièche I, 1999, GENE CHROMOSOME CANC, V24, P255, DOI 10.1002/(SICI)1098-2264(199903)24:3<255::AID-GCC11>3.0.CO
[9]  
2-2
[10]   Unbiased location analysis of E2F1-binding sites suggests a widespread role for E2F1 in the human genome [J].
Bieda, M ;
Xu, XQ ;
Singer, MA ;
Green, R ;
Farnham, PJ .
GENOME RESEARCH, 2006, 16 (05) :595-605